| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.014 | 0.9 |